U.S. markets open in 1 hour 40 minutes

LogicBio Therapeutics, Inc. (LOGC)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
6.31-0.09 (-1.41%)
At close: 4:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 11/21/2020
Current
9/30/20206/30/20203/31/202012/31/20199/30/2019
Market Cap (intraday) 5
192.63M215.06M198.85M114.69M165.87M246.10M
Enterprise Value 3
176.64M194.67M165.76M74.36M102.70M183.41M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
48.41105.29189.07N/AN/AN/A
Price/Book (mrq)
8.647.645.902.713.123.88
Enterprise Value/Revenue 3
60.66210.23171.7772.83N/AN/A
Enterprise Value/EBITDA 6
-4.96-25.48-21.16-8.19-9.26-17.37

Trading Information

Stock Price History

Beta (5Y Monthly) 1.17
52-Week Change 3-21.52%
S&P500 52-Week Change 315.56%
52 Week High 311.60
52 Week Low 33.05
50-Day Moving Average 36.03
200-Day Moving Average 37.10

Share Statistics

Avg Vol (3 month) 3194.65k
Avg Vol (10 day) 3100.34k
Shares Outstanding 531.79M
Float 15.4M
% Held by Insiders 113.68%
% Held by Institutions 151.44%
Shares Short (Nov 12, 2020) 4501.52k
Short Ratio (Nov 12, 2020) 43.76
Short % of Float (Nov 12, 2020) 42.38%
Short % of Shares Outstanding (Nov 12, 2020) 41.58%
Shares Short (prior month Oct 14, 2020) 4433.92k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,253.47%

Management Effectiveness

Return on Assets (ttm)-41.90%
Return on Equity (ttm)-98.52%

Income Statement

Revenue (ttm)2.91M
Revenue Per Share (ttm)0.12
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -36.05M
Net Income Avi to Common (ttm)-37.19M
Diluted EPS (ttm)-1.60
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)32.28M
Total Cash Per Share (mrq)1.02
Total Debt (mrq)16.3M
Total Debt/Equity (mrq)73.11
Current Ratio (mrq)6.21
Book Value Per Share (mrq)0.94

Cash Flow Statement

Operating Cash Flow (ttm)-33.14M
Levered Free Cash Flow (ttm)-20.55M